..... news could be the marrying of the parts for AMD with some good news from the fluorescent thingies. Maybe a spike for that but is it the sort of pre-clinical they need, as far raising the SP? Doubtful. I would think they will need to virtually trial the combined product in NHPs and have some success. Sounds time consuming and expensive. More than six months IMO.
Maybe HBV..... Well BB-101 seems already out of date but they will have news anyway. With and without chemical help. This may be a nice lead into BB -103 but again, it's going to take excellent NHP pre-clinical, to save from major dilution. That won't happen in six months either.
- Forums
- ASX - By Stock
- BLT
- Ann: BENITEC ANNOUNCES TT-034 CLINICAL STUDY RESULTS-BLT.AX
Ann: BENITEC ANNOUNCES TT-034 CLINICAL STUDY RESULTS-BLT.AX, page-66
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online